Ehealth: Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome

doi:10.3748/wjg.v20.i43.16215

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17294)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

1425

WORD

485

HTML

11867

Figures (1-5)

179

Tables (1-4)

167

Sum=14123

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1417

Download

1754

Sum=3171

Nov 21, 2014 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (134)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Nov 21, 2014; 20(43): 16215-16226
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16215

Table 1 Baseline characteristics of patients with irritable bowel syndrome

Characteristics	LFD, n = 42	LGG, n = 41	ND, n = 40	P = 0.23
Male/Female	8/34	14/27	11/29	0.30
Age (yr, range)	37 (18-71)	43 (20-74)	32 (18-73)	0.08
BMI (range)	23 (19-38)	22 (18-34)	23 (17-34)	0.50
Smoking				0.92
Current	5 (12)	6 (15)	6 (15)
Former	8 (19)	11 (27)	11 (27)
Never	24 (57)	22 (54)	22 (55)
Missing	5	2	1
Disease duration (yr, range)	2.6 (0.7-13)	1.8 (0.7-15)	2 (0.5-9)	0.20
Diagnosis subtypes				0.24
IBS-A, mixed	14 (33)	19 (46)	14 (35)
IBS-C, constipation	5 (12)	7 (17)	7 (17)
IBS-D, diarrhoeal	19 (45)	13 (32)	18 (35)
Unknown	4	2	1
Abdominal surgery	7 (17)	9 (22)	6 (15)	0.40
IBS related medication	16 (38)	15 (37)	18 (45)	0.40
IBS-SSS	327 ± 94	279 ± 84	319 ± 83	0.17
IBS-QOL	56 ± 21	64 ± 15	57 ± 22	0.24

Data are expressed as n (%), mean ± SD or median (range). FODMAP: Fermentable, oligosaccharides, disaccharides, monosaccharides and polyols; LFD: Low FODMAP diet; LGG: Lactobacillus rhamnosus GG; ND: Normal (Danish/Western) diet; IBS: Irritable bowel syndrome; SSS: Severity score system; IBS-QOL: IBS-quality of life; IBS-A: Alternation of constipation and diarrhoea; IBS-D: Irritable bowel syndrome-diarrhoea predominant; IBS-C: Irritable bowel syndrome-constipation predominant.

Table 2 Change of the irritable bowel syndrome-severity score system from baseline and after 6-wk

	IBS-D			IBS-A			IBS-C
	Baseline	6-wk	P value	Baseline	6-wk	P value	Baseline	6-wk	P value
LFD	320 ± 110	153 ± 136	< 0.01¹	359 ± 66	241 ± 111	0.01¹	289 ± 79	200 ± 62	0.14
LGG	297 ± 99	199 ± 102	0.01¹	251 ± 64	187 ± 122	0.04¹	321 ± 79	270 ± 145	0.74
ND	320 ± 89	257 ± 118	0.01¹	312 ± 99	322 ± 62	0.12	302 ± 70	277 ± 135	0.61

Change of the irritable bowel syndrome-severity score system from baseline and after 6-wk with low fermentable, oligosaccharides, disaccharides, monosaccharides and polyols diet (LFD) vs Lactobacillus rhamnosus GG (LGG) vs normal (Danish/Western) diet (ND) in different subtypes of IBS patients. Wilcoxon related samples: mean IBS-SSS ± SD. IBS: Irritable bowel syndrome; IBS-D: Diarrhoea predominant; IBS-C: Constipation predominant; IBS-A: Alternating of diarrhoea and constipation.

¹Significant result.

Table 3 Factors influencing positive changes in irritable bowel syndrome-severity score system at follow-up

Effect	Contrast	Diff SSS	Lower	Upper	P value
Age	Below 40 yr vs above	38.0246	-9.4334	85.4826	0.11
BMI	kg/m²	0.1812	-5.1063	5.4687	0.94
Gender	Females vs males	8.4693	-45.6473	62.5859	0.75
IBS subtype	IBS-A vs IBS-D	46.1096	0.6579	91.5613	0.04¹
IBS subtype	IBS-C vs IBS-D	50.3197	-7.1618	107.80	0.08
IBS medication	Yes vs no	-54.8795	-98.4657	-11.2933	0.01¹
Prior surgery	Yes vs no	-11.6029	-62.1065	38.9007	0.64
IBS-SSS	Per baseline SSS point	-0.4082	-0.6566	-0.1598	0.001¹
Smoking	Current vs never	66.0478	1.0815	131.01	0.04¹
Smoking	Former vs never	51.6542	3.8682	99.4401	0.03¹
IBS duration	Per year	4.7145	-3.0897	12.5188	0.23
Treatment group	LGG vs ND	-31.5190	-80.7763	17.7384	0.20
Treatment group	LFD vs ND	-75.3656	-126.81	-23.9216	0.004¹
Treatment group	LGG vs LFD	43.8466	-8.0787	95.7720	0.09

Irritable bowel syndrome-severity score system (IBS-SSS) outcome adjusted for baseline covariates: gender, age at diagnosis, smoking status, IBS subtype, surgery, medication, disease duration and body mas index (BMI). IBS duration, baseline IBS-SSS and treatment modality were used as regression variables ± 95%CI: Lower-upper). LFD: Low fermentable, oligosaccharides, disaccharides, monosaccharides and polyols diet; LGG: Lactobacillus rhamnosus GG; ND: Normal (Danish/Western) diet; Diff SSS: IBS-SSS difference.

¹Significant result.

Table 4 Factors influencing positive changes in irritable bowel syndrome quality of life at follow-up

Effect	Contrast	Diff QOL	Lower	Upper	P value
Age	Below 40 yr vs above	-6.3823	-13.6223	0.8577	0.08
BMI	Per kg/m²	-0.2785	-1.1185	0.5615	0.51
Gender	Females vs males	2.2012	-6.3816	10.7840	0.61
IBS subtype	IBS-A vs IBS-D	-6.4508	-13.7027	0.8012	0.08
IBS subtype	IBS-C vs IBS-D	-4.3839	-13.5478	4.7800	0.34
IBS medication	Yes vs no	7.9708	1.0208	14.9209	0.02¹
Prior surgery	Yes vs no	6.1371	-1.9592	14.2335	0.13
IBS-QOL	Per baseline QOL point	-0.2972	-0.4739	-0.1205	0.001¹
Smoking	Current vs never	-6.2665	-16.7074	4.1743	0.23
Smoking	Former vs never	-6.9729	-14.6297	0.6839	0.07
Time from diagnosis	Per year	-0.1678	-1.4072	1.0716	0.78
Treatment group	LGG vs ND	7.2158	-0.5844	15.0160	0.06
Treatment group	LFD vs ND	3.7883	-4.4003	11.9769	0.36
Treatment group	LGG vs LFD	3.4275	-4.8844	11.7395	0.41

Irritable bowel syndrome quality of life (IBS-QOL) outcome adjusted for baseline covariates: gender, age, smoking status, IBS subtype, Prior abdominal surgery, IBS medication, IBS duration and body mass index (BMI). IBS duration, baseline IBS-QOL and treatment modality were used as regression variables ± 95%CI: Upper-lower). LFD: Low fermentable, oligosaccharides, disaccharides, monosaccharides and polyols diet; LGG: Lactobacillus rhamnosus GG; ND: Normal (Danish/Western) diet; Diff QOL: IBS-QOL difference.

¹Significant result.

Citation: Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm P. Ehealth: Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014; 20(43): 16215-16226
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16215.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16215